Treatment with intravenous gammaglobulin in pediatric patients with primary vasculitis
Acta Pediátrica de México, 2014 Nowadays intravenous immunoglobulins have been used in differ- ent vasculitis with various results for each condition, being more recommended for its use in Kawasaki disease and ANCA-associated vasculitis.
Camacho Meza Ignacio +1 more
doaj +1 more source
Guillain-Barre syndrome (GBS) [PDF]
, 2013 A 57-year-old Caucasian gentleman presented with bilateral progressive distal upper limb paraesthesiae, which he described as a feeling of “heaviness” followed by distal lower limb and mild tongue parasthaesia.
Grima, Maria Angela
core
IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease [PDF]
, 2019 Our previous studies showed that intravenous immunoglobulin (IVIG) contained anti-Aβ autoantibodies that might be able to treat Alzheimer's disease (AD).
Dodel, Richard +10 more
core +1 more source
"Synergistic Effect of Intravenous Immunoglobulins and Iodinated Contrast Media on Renal Function "
Iranian Journal of Allergy, Asthma and Immunology, 2004 Acute renal failure is one of the side effects while using intravenous immunoglobulins. This complication is also observed with iodinated contrast media.
Mojgan Safari +2 more
doaj
New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients [PDF]
, 2017 Immunoglobulin replacement therapy (IRT) is standard treatment for patients with primary immunodeficiency (PID). Because most of the patients with PID will require long life-time immunoglobulin replacement therapy, the quality of the prescribed ...
Alfa Cissé, Ousmane +6 more
core
Antigen-specific electrophoretic cell separation for immunological investigations [PDF]
, 1989 Preincubation of human blood lymphocytes with cell surface antigen specific antibodies under non-capping conditions reduces the electrophoretic mobility of the corresponding lymphocyte subpopulation.
Hannig, K. +2 more
core +1 more source
Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? [PDF]
, 2008 Antibody-based therapeutics currently enjoy unprecedented success, growth in research and revenues, and recognition of their potential. It appears that the promise of the "magic bullet" has largely been realized.
Dimitrov, Dimiter S, Marks, James D
core +1 more source
Advances in the design and development of oncolytic measles viruses. [PDF]
, 2015 A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has
Hutzen, Brian +2 more
core +1 more source
Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series
Therapeutic Advances in HematologyAcquired von Willebrand syndrome (AVWS) is a well-known complication of a monoclonal gammopathy with a potentially severe bleeding tendency. Treatment with von Willebrand factor (VWF)/factor VIII (FVIII) concentrate yields mixed results in controlling ...
Quentin Van Thillo +11 more
doaj +1 more source
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies [PDF]
, 2015 Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia
Kay, Kathleen Alexandra
core +1 more source